Sep 4 |
ACHV: New Skipper at the Helm
|
Aug 19 |
ACHV: ORCA OL Enrolling at Rapid Pace
|
Aug 14 |
Achieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call Transcript
|
Aug 13 |
Achieve Life Sciences GAAP EPS of -$0.25 misses by $0.01
|
Aug 13 |
Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
|
Jul 31 |
Achieve gets FDA breakthrough status for vaping cessation drug
|
Jul 31 |
Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
|
Jul 29 |
Achieve Life Sciences announces $20M loan refinancing
|
Jul 29 |
Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank
|
Jul 25 |
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
|